These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34904579)

  • 1. Platelet-Rich Plasma in Melasma-A Systematic Review.
    Sarkar R; Gupta M
    Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-rich plasma treatment for melasma: A pilot study.
    Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
    J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of TGF-β protein in the lesional skins of melasma patients following treatment with platelet-rich plasma.
    Hofny ERM; Hussein MRA; Ghazally A; Ahmed AM; Abdel-Motaleb AA
    J Cosmet Laser Ther; 2019; 21(7-8):382-389. PubMed ID: 31554441
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet-rich plasma is a promising therapy for melasma.
    Tuknayat A; Bhalla M; Thami GP
    J Cosmet Dermatol; 2021 Aug; 20(8):2431-2436. PubMed ID: 34013618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma.
    Gamea MM; Kamal DA; Donia AA; Hegab DS
    J Dermatolog Treat; 2022 Mar; 33(2):798-804. PubMed ID: 32567984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
    Abd Elraouf IG; Obaid ZM; Fouda I
    Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment.
    Polat Y; Saraç G
    Dermatol Ther; 2022 Jul; 35(7):e15499. PubMed ID: 35395121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of platelet-rich plasma efficacy in melasma.
    Acar A; Ozturk A; Sokmen N; Unal I; Ertam Sagduyu I
    J Cosmet Laser Ther; 2022 Jul; 24(1-5):36-39. PubMed ID: 35852165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
    Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
    J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-rich plasma is a useful therapeutic option in melasma.
    Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
    J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
    [No Abstract]   [Full Text] [Related]  

  • 11. The Vascular Component of Melasma: A Systematic Review of Laboratory, Diagnostic, and Therapeutic Evidence.
    Masub N; Nguyen JK; Austin E; Jagdeo J
    Dermatol Surg; 2020 Dec; 46(12):1642-1650. PubMed ID: 33252894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic Acid for Melasma Treatment: A Split-Face Study.
    Ebrahim HM; Said Abdelshafy A; Khattab F; Gharib K
    Dermatol Surg; 2020 Nov; 46(11):e102-e107. PubMed ID: 32701529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
    Adel S; Serri A; Abd El-Raheem T
    Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
    Patil NK; Bubna AK
    Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of the Efficacy and Safety of Microneedling in the Treatment of Melasma.
    Wu SZ; Muddasani S; Alam M
    Dermatol Surg; 2020 Dec; 46(12):1636-1641. PubMed ID: 32897944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
    Bailey AJM; Li HO; Tan MG; Cheng W; Dover JS
    J Am Acad Dermatol; 2022 Apr; 86(4):797-810. PubMed ID: 33857549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of atrophic acne scars using autologous platelet-rich plasma vs combined subcision and autologous platelet-rich plasma: A split-face comparative study.
    Hassan AS; El-Hawary MS; Abdel Raheem HM; Abdallah SH; El-Komy MM
    J Cosmet Dermatol; 2020 Feb; 19(2):456-461. PubMed ID: 31241854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
    Feng X; Su H; Xie J
    J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.
    Kaur A; Bhalla M; Pal Thami G; Sandhu J
    Dermatol Surg; 2020 Nov; 46(11):e96-e101. PubMed ID: 32769524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.